Publications

Detailed Information

Inflammation-related immune proteins in maternal plasma as potential predictive biomarkers for rescue cerclage outcome in women with cervical insufficiency

Cited 1 time in Web of Science Cited 1 time in Scopus
Authors

Kim, So Yeon; Park, Kyo Hoon; Kim, Hyeon Ji; Kim, Yu Mi; Ahn, Kwanghee; Lee, Kyong-No

Issue Date
2022-07
Publisher
Blackwell Publishing Inc.
Citation
American Journal of Reproductive Immunology, Vol.88 No.1, p. e13557
Abstract
© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.Problem: This study aimed to determine whether various novel plasma mediators of immune regulation associated with inflammation could independently predict the clinical outcome of rescue cerclage in patients with cervical insufficiency (CI). Method of study: A total of 41 singleton pregnant women (17–25 weeks) who underwent rescue cerclage for CI were retrospectively evaluated. Stored plasma samples were assayed for IGFBP-1, -2, -3, IL-6, latexin, LBP, lipocalin-2, M-CSF, MIP-1α, MMP-8, -9, pentraxin 3, resistin, S100A8, S100A8/A9, thrombospondin-2, TIMP-1, and TNFR2 levels. The primary outcome measures were spontaneous preterm birth (SPTB) at < 28 and < 34 weeks after cerclage placement. Results: Multivariate Firth's logistic regression analysis revealed that high levels of IGFBP-3 and S100A8/A9, and low levels of MIP-1α were significantly associated with SPTB at < 28 weeks after cerclage placement, whereas only low MIP-1α levels were significantly associated with SPTB at < 34 weeks, even after adjustment for baseline clinical covariates (e.g., cervical dilatation). For the prediction of SPTB at < 28 weeks, the area under the curves (AUC) of IGFBP-3, MIP-1α, and S100A8/A9 were of.686,.691, and.693, respectively. Similarly, the AUC of MIP-1 α was of.659 to predict SPTB at < 34 weeks. Conclusions: These findings suggest that plasma IGFBP-3, MIP-1α, and S100A8/A9 can represent noninvasive independent biomarkers for identifying women with CI at high risk for SPTB following rescue cerclage. Nonetheless, further in large, multicenter clinical studies should be performed to confirm the clinical value of these biomarkers.
ISSN
1046-7408
URI
https://hdl.handle.net/10371/184671
DOI
https://doi.org/10.1111/aji.13557
Files in This Item:
There are no files associated with this item.
Appears in Collections:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share